Donna Stock-Novack

891 citations
11 papers · 673 indexed · h-index 10
Topics
Multiple Myeloma Research and Treatments (4 papers)Ovarian cancer diagnosis and treatment (4 papers)Chemotherapy-induced organ toxicity mitigation (3 papers)

In The Last Decade

Donna Stock-Novack

11 papers receiving 638 citations

Peers

Donna Stock-Novack
Comparison fields: 5 of 62
  • Oncology 249
  • Hematology 246
  • Molecular Biology 181
  • Reproductive Medicine 179
  • Surgery 154
Replace Jeffrey Schneider with:
Jeffrey Schneider United States
Luigi Salvagno Italy
J Chauvergne France
A. Bamias Greece
J. F. Pringle Canada
A.B.W. Nethersell United Kingdom
W. E. C. Allt Canada
M.R. Sertoli Italy
F Carnino Italy
M. R. Sertoli Italy
Donna Stock-Novack relative to Jeffrey Schneider United States Jeffrey Schneider's profile →
Citations per field
00.5×2.9×
Jeffrey Schneider · 1×
Citations per year

Countries citing papers authored by Donna Stock-Novack

Since Specialization
Citations

This map shows the geographic impact of Donna Stock-Novack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Stock-Novack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Stock-Novack more than expected).

Fields of papers citing papers by Donna Stock-Novack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Stock-Novack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Stock-Novack. The network helps show where Donna Stock-Novack may publish in the future.

Co-authorship network of co-authors of Donna Stock-Novack

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Stock-Novack. A scholar is included among the top collaborators of Donna Stock-Novack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Stock-Novack. Donna Stock-Novack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 16
2 13
3 10
4
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.
55
5 225
6 1
7 12
8 12
9 126
10 133
11 70

About Donna Stock-Novack

Donna Stock-Novack is a scholar working on Reproductive Medicine, Hematology and Genetics, having authored 11 papers that have together received 673 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). The work is most often cited by research in Hematology (246 citations), Reproductive Medicine (179 citations) and Genetics (116 citations). Donna Stock-Novack has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include John Crowley, SE Salmon, Coltman Ca, Patrick R. Finley, BG Durie, David S. Alberts, Earl A. Surwit, Edward V. Hannigan, Robert V. O’Toole and William A. Nahhas. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026